Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with antacids.
Source: Harrison 22e · unknown
Antiviral agent for influenza (cap-dependent endonuclease inhibitor)
Baloxavir inhibits the cap-dependent endonuclease that is important in initiating synthesis of influenza virus mRNA.
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with antacids.
Source: Harrison 22e · unknown
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with oral supplements containing calcium.
Source: Harrison 22e · unknown
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with dairy products.
Source: Harrison 22e · unknown
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with oral supplements containing iron.
Source: Harrison 22e · unknown
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with oral supplements containing magnesium.
Source: Harrison 22e · unknown
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with polyvalent cation-containing laxatives.
Source: Harrison 22e · unknown
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with oral supplements containing selenium.
Source: Harrison 22e · unknown
Reduced plasma levels and potential loss of efficacy of baloxavir.
Avoid taking baloxavir with oral supplements containing zinc.
Source: Harrison 22e · unknown
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team